Inspection opinions of Haitong Securities Co., Ltd. on the information disclosure regulatory inquiry letter on the 2023 annual report of Shanghai Fudan Zhangjiang Biomedical Co., Ltd.

SZSI · Apr 30

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.